Benathen Marc David's Form 4 filing
LifeMD, Inc. (LFMD) · filed Aug 18, 2021
- Accession no.
- 0001362118-21-000029
- Filed
- Aug 18, 2021
- Trade date
- Aug 18, 2021
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions. Open-market purchases total $22.3K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Benathen Marc DavidCIK 0001845258 | Officer (Chief Financial Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 18, 2021 | Common Stock | PPurchaseAcquired | +1,297 | $7.23 | +$9,377.31 | 17,953 | Direct | |
| Aug 18, 2021 | Common Stock | PPurchaseAcquired | +1,300 | $7.26 | +$9,438 | 19,253 | Direct | |
| Aug 18, 2021 | Common Stock | PPurchaseAcquired | +64 | $7.29 | +$466.56 | 19,317 | Direct | |
| Aug 18, 2021 | Common Stock | PPurchaseAcquired | +63 | $7.24 | +$456.12 | 19,380 | Direct | |
| Aug 18, 2021 | Common Stock | PPurchaseAcquired | +343 | $7.43 | +$2,548.49 | 19,723 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.